Verve Therapeutics gets grant for gene editing compositions to lower ldl cholesterol levels

Discover how Verve Therapeutics’ new patent for gene editing targeting the PCSK9 gene could revolutionize LDL cholesterol treatment and combat cardiovascular disease.

Meta Title: “Precigen Inc Patent: Insect Population Control with Lethal Gene Expression

Share this article According to GlobalData’s company profile on Precigen, Cancer treatment biomarkers was a key innovation area identified from patents. Precigen‘s grant share as

March 6, 2024

RIT researchers use CRISPR to develop new treatment for degenerative disc disease

Rochester Institute of Technology researchers are improving non-invasive treatment options for degenerative disc disease, an ailment that impacts 3 million adults yearly in the U.S.,

September 7, 2023

A Swell Of Insider Purchases Follow Cybin Inc.’s Positive Year-End Update | Psychedelic Invest

Miami, Florida–(Newsfile Corp. – July 8, 2024) – Fast-moving sectors need equally fast-moving companies, a box that Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN)

July 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.